8 Hrs
Source:
وكالة الانباء العراقية (واع)
Russia developing hepatitis B gene therapy
Sechenov University of Russia, in collaboration with R-Pharm Pharmaceuticals, has begun developing a new drug targeting hepatitis B virus using CRISPR-Cas9 gene editing technology. The project aims to provide an effective treatment for the disease and is now in advanced stages of research and development after receiving a grant named after Academician E. P. Vilekhov.
Size: 120%Text Size
Notice: This Is an AI-Generated Summary
Comments (0)